Clinical Trial Update: Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and results posting of a Phase 2 open-label extension study of ABT-122 in rheumatoid arthritis patients who co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ABT-122

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-19